OncoPep
Amanda joined OncoPep in 2023 as a Scientist specializing in immuno-oncology. She received her PhD in Cancer Biology from Emory University in Atlanta, GA, where she investigated the role of MEK inhibition in combination with immune checkpoint inhibitors in advanced biliary tract cancer. Previously, she received both her Bachelor of Science in Biological Sciences and Master of Science in Cellular and Molecular Biology from Quinnipiac University in Hamden, CT.
This person is not in any offices
OncoPep
Through targeting multiple tumor-associated antigens with an investigational multi-peptide vaccine and a multi-tumor antigen adoptive (MTAA) T cell therapy, OncoPep’s T cell-focused technologies are designed to be used on their own or in combination with other immunotherapeutics.